Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

A prospective evaluation of C-reactive protein levels and colorectal adenoma development.

Gunter MJ, Cross AJ, Huang WY, Stanczyk FZ, Purdue M, Xue X, Schoen R, Limburg PJ, Schatzkin A, Sinha R, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):537-44. doi: 10.1158/1055-9965.EPI-10-1099. Epub 2011 Jan 6.

PMID:
21212059
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.

Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA.

Int J Cancer. 2008 Sep 1;123(5):1133-40. doi: 10.1002/ijc.23606. Review.

PMID:
18528865
[PubMed - indexed for MEDLINE]
3.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

PMID:
20594533
[PubMed - indexed for MEDLINE]
Free Article
4.

A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Heikkilä K, Ebrahim S, Lawlor DA.

J Epidemiol Community Health. 2007 Sep;61(9):824-33. Review.

PMID:
17699539
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk